---
title: "Alaunos Therapeutics plunges 32% after $1.12M direct offering"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299473003.md"
description: "TCRT plunges 32% in regular trading to $1.09 after completing a $1.12M registered direct offering and amending quorum rules."
datetime: "2026-09-18T16:42:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299473003.md)
  - [en](https://longbridge.com/en/news/299473003.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299473003.md)
generator: "portal-rs"
---

# Alaunos Therapeutics plunges 32% after $1.12M direct offering

Alaunos Therapeutics(TCRT.US) 盘中跌**31.87%**，现报**1.09 美元**。

该公司此前完成**112 万美元**的注册直接发行，并修订了法定人数规则。消息公布后股价出现显著回调。

### Related Stocks

- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)

## Related News & Research

- [Alaunos Therapeutics Announces New Registered Direct Offering](https://longbridge.com/en/news/299813835.md)
- [Alaunos Therapeutics Enters Securities Purchase Agreement With Accredited Investors](https://longbridge.com/en/news/299810727.md)
- [Alaunos Therapeutics cuts stockholder meeting quorum requirement to one-third from majority](https://longbridge.com/en/news/299300336.md)
- [Alaunos net loss narrows to $1.9 million in Q2 2026; revenue posts no revenue in H1 2026](https://longbridge.com/en/news/295974259.md)
- [Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies | TCRT Stock News](https://longbridge.com/en/news/287654720.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**